Amber Yates: Stretching Scientific Muscles in Areas of Hematology – Day 2 at EHA 2026
Amber Yates, Senior Medical Director and Global Medical Affairs Leader at Agios Pharmaceuticals, shared a post on LinkedIn:
“EHA 2026 – Day 2
Day 2 at EHA 2026 is about diving back in — stretching scientific muscles in areas of hematology that I haven’t spent as much time in recently.
There’s something energizing about stepping outside of your usual space and reconnecting with the depth and breadth of rare disease research.
From novel mechanisms to evolving treatment paradigms, it’s a powerful reminder of how much innovation is happening across our field.
Every session brings new perspectives that ultimately make us better at what we do for patients.
On a personal level, today is also building a sense of anticipation and pride as we head into tomorrow.
I’m incredibly excited for Agios to share our sickle cell data from rise up — work that reflects deep collaboration, scientific rigor, and most importantly, a commitment to improving outcomes for people living with sickle cell.
Grateful for the learning, the conversations, and the constant push to grow.”
Stay updated with Hemostasis Today.
-
Jun 14, 2026, 19:41Peter Loffelhardt: Thousands of People Coming in – Second Day at EHA 2026
-
Jun 14, 2026, 19:32Highlights from Day 1 at the EHC Leadership Conference 2026
-
Jun 14, 2026, 18:01Ahmar U. Zaidi: The First Pivotal Study of a New Mechanism in Sickle Cell Disease
-
Jun 14, 2026, 18:00Lennart Lenk: Witnessing Former Boss Deliver a Plenary Talk at EHA 2026
-
Jun 14, 2026, 18:00Priya Sriskandarajah: Great Presentations on Recent Advances in Myelofibrosis at EHA 2026
-
Jun 14, 2026, 18:00Tania Lifanova: Another Year of Building Relationships at EHA
-
Jun 14, 2026, 17:59Pratap Kumar: Blood Shortages Are a Health Systems Challenge, Not Just a Donor Shortage
-
Jun 14, 2026, 17:59John Ohd: 3 Great Reasons to Join us Here at EHA 2026
-
Jun 14, 2026, 16:16Andreas Kronbichler: The Intronic Splice-Site Variants in Complement-Mediated Thrombotic Microangiopathy